Albireo Pharma Price on December 23, 2022
ALBODelisted Stock | USD 44.15 0.75 1.67% |
If you're considering investing in Albireo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Albireo Pharma stands at 44.15, as last reported on the 9th of May, with the highest price reaching 44.90 and the lowest price hitting 44.00 during the day. We have found twenty-nine technical indicators for Albireo Pharma, which you can use to evaluate the volatility of the firm. Please confirm Albireo Pharma's risk adjusted performance of 0.089, and Mean Deviation of 3.65 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Albireo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Albireo |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ALBO |
Based on monthly moving average Albireo Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Albireo Pharma by adding Albireo Pharma to a well-diversified portfolio.
Albireo Pharma Valuation on December 23, 2022
It is possible to determine the worth of Albireo Pharma on a given historical date. On December 23, 2022 Albireo was worth 19.91 at the beginning of the trading date compared to the closed value of 19.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Albireo Pharma stock. Still, in general, we apply an absolute valuation method to find Albireo Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Albireo Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Albireo Pharma's related companies.
Open | High | Low | Close | Volume | |
19.61 | 20.08 | 19.39 | 19.97 | 82,400 | |
12/23/2022 | 19.91 | 20.15 | 19.05 | 19.37 | 142,300 |
19.38 | 19.74 | 17.82 | 18.01 | 154,366 |
Backtest Albireo Pharma | | | Albireo Pharma History | | | Albireo Pharma Valuation | Previous | Next |
Albireo Pharma Trading Date Momentum on December 23, 2022
On December 27 2022 Albireo Pharma was traded for 18.01 at the closing time. The top price for the day was 19.74 and the lowest listed price was 17.82 . The trading volume for the day was 154.4 K. The trading history from December 27, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.02% . The overall trading delta against the current closing price is 12.55% . |
Albireo Pharma Fundamentals Correlations and Trends
By evaluating Albireo Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Albireo Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Albireo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Albireo Pharma Stock history
Albireo Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Albireo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Albireo Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Albireo Pharma stock prices may prove useful in developing a viable investing in Albireo Pharma
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts. Albireo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 130 people.
Albireo Pharma Stock Technical Analysis
Albireo Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Albireo Pharma Period Price Range
Low | December 23, 2022
| High |
19.91 | 19.37 |
Albireo Pharma May 9, 2024 Market Strength
Market strength indicators help investors to evaluate how Albireo Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Albireo Pharma shares will generate the highest return on investment. By undertsting and applying Albireo Pharma stock market strength indicators, traders can identify Albireo Pharma entry and exit signals to maximize returns
Accumulation Distribution | 7768.24 | |||
Daily Balance Of Power | (0.49) | |||
Rate Of Daily Change | 0.97 | |||
Day Median Price | 19.6 | |||
Day Typical Price | 19.52 | |||
Price Action Indicator | (0.50) | |||
Period Momentum Indicator | 24.78 |
Albireo Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Albireo Pharma's price direction in advance. Along with the technical and fundamental analysis of Albireo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Albireo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.089 | |||
Jensen Alpha | 1.44 | |||
Total Risk Alpha | 0.024 | |||
Sortino Ratio | 0.6286 | |||
Treynor Ratio | 2.41 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Albireo Stock
If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |